Cyclerion Therapeutics (CYCN) Retained Earnings (2019 - 2025)
Historic Retained Earnings for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to -$270.2 million.
- Cyclerion Therapeutics' Retained Earnings fell 82.05% to -$270.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$270.2 million, marking a year-over-year decrease of 82.05%. This contributed to the annual value of -$267.5 million for FY2024, which is 116.29% down from last year.
- As of Q3 2025, Cyclerion Therapeutics' Retained Earnings stood at -$270.2 million, which was down 82.05% from -$269.2 million recorded in Q2 2025.
- In the past 5 years, Cyclerion Therapeutics' Retained Earnings registered a high of -$176.8 million during Q1 2021, and its lowest value of -$270.3 million during Q2 2023.
- In the last 5 years, Cyclerion Therapeutics' Retained Earnings had a median value of -$264.4 million in 2023 and averaged -$247.9 million.
- As far as peak fluctuations go, Cyclerion Therapeutics' Retained Earnings tumbled by 6704.74% in 2021, and later skyrocketed by 110.62% in 2024.
- Quarter analysis of 5 years shows Cyclerion Therapeutics' Retained Earnings stood at -$215.1 million in 2021, then decreased by 20.49% to -$259.2 million in 2022, then fell by 2.03% to -$264.4 million in 2023, then dropped by 1.16% to -$267.5 million in 2024, then fell by 1.02% to -$270.2 million in 2025.
- Its last three reported values are -$270.2 million in Q3 2025, -$269.2 million for Q2 2025, and -$268.9 million during Q1 2025.